This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Plasmepsin
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | + | ||
| + | <StructureSection load='4cku' size='350' side='right' caption='Plasmepsin II complex with a potential antimalarial drug (PDB entry [[4cku]])' scene=''> | ||
== Function == | == Function == | ||
[[Plasmepsin]] (Plm) is a hemoglobin-degrading enzyme produced by the plasmodium parasite. It is an aspartic acid protease having 2 aspartic acid residues in the active site. Ten Plm isoforms are known which are named Plm I, II, etc and '''Histo-Aspartic Protease (HAP)'''. | [[Plasmepsin]] (Plm) is a hemoglobin-degrading enzyme produced by the plasmodium parasite. It is an aspartic acid protease having 2 aspartic acid residues in the active site. Ten Plm isoforms are known which are named Plm I, II, etc and '''Histo-Aspartic Protease (HAP)'''. | ||
| Line 7: | Line 8: | ||
==Relevance == | ==Relevance == | ||
Plm is a potential target for anti-malaria drugs<ref>PMID:25719272</ref>. | Plm is a potential target for anti-malaria drugs<ref>PMID:25719272</ref>. | ||
| + | |||
| + | == Structural highlights == | ||
<br /> | <br /> | ||
Revision as of 08:53, 4 July 2016
| |||||||||||
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, Alexander Berchansky, Joel L. Sussman, Jaime Prilusky
